Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. IOSP
IOSP logo

IOSP Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
70.640
Open
70.640
VWAP
70.64
Vol
2.63K
Mkt Cap
1.75B
Low
70.640
Amount
185.71K
EV/EBITDA(TTM)
7.14
Total Shares
24.78M
EV
1.46B
EV/OCF(TTM)
10.58
P/S(TTM)
0.99
Innospec Inc. develops, manufactures, blends, markets, and supplies a wide range of specialty chemicals to customers in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. The Company operates through three segments: Performance Chemicals, Fuel Specialties and Oilfield Services. The Company’s Performance Chemicals business creates technology-based solutions for the personal care, home care, agrochemical, construction, mining, and other industrial markets. This segment serves multinational companies, manufacturers of personal care and home care products and global mining, agricultural and building products and other industrial companies. The Company’s Fuel Specialties segment develops, manufactures, blends, markets, and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Company’s Oilfield Services business supplies drilling, completion, and production chemicals.
Show More

Events Timeline

(ET)
2026-02-17
16:50:00
Innospec Reports Q4 Revenue of $455.6M
select
2025-08-05 (ET)
2025-08-05
17:28:16
Innospec reports Q2 EPS 94c, consensus $1.21
select
2025-03-10 (ET)
2025-03-10
16:46:38
Innospec approves new $50M share buyback program
select
2025-03-03 (ET)
2025-03-03
09:12:48
Innospec expands production of drag reducing agents
select

News

seekingalpha
9.5
02-18seekingalpha
Innospec Inc. Q4 2025 Earnings Call Insights
  • Revenue Performance: Innospec reported total revenues of $455.6 million for Q4, a 2% decline year-over-year, yet achieved a 7% increase in operating income within Fuel Specialties, indicating strong performance in diversified markets.
  • Margin Changes: Overall gross margin decreased by 1.2 percentage points to 28% year-over-year; however, Fuel Specialties maintained a robust gross margin of 34.7%, suggesting continued profitability and potential for driving overall company performance.
  • Future Outlook: Management anticipates full-year improvements in Performance Chemicals and Oilfield Services for 2026, despite Q1 disruptions from a historic winter storm, maintaining optimism particularly in new technologies and product innovations.
  • Cost Control: Corporate costs for Q4 decreased to $16 million, down $4.6 million from the previous year, reflecting effective measures in personnel cost management, thereby strengthening the financial foundation for future investments and shareholder returns.
seekingalpha
9.5
02-17seekingalpha
Innospec Q4 Earnings Beat Expectations Despite Revenue Miss
  • Earnings Beat: Innospec reported a Q4 non-GAAP EPS of $1.50, exceeding expectations by $0.26, indicating strong profitability despite revenue challenges, which reflects effective cost management.
  • Revenue Decline: The company’s revenue of $455.6 million fell 2.4% year-over-year and missed estimates by $5.27 million, highlighting the impact of fluctuating market demand on overall performance.
  • Pressure on Personal Care Margins: While margins in the personal care segment are under pressure, analysts believe the market cycle will eventually turn, suggesting that the company retains long-term growth potential in this sector.
  • Positive Market Reaction: Despite the revenue miss, investors reacted positively to the strong EPS performance, which may enhance market confidence in Innospec's future earnings, potentially driving stock price appreciation.
Yahoo Finance
9.5
02-17Yahoo Finance
Innospec Reports Q4 Adjusted Earnings Growth
  • Earnings Growth: Innospec reported Q4 adjusted earnings of $1.50 per diluted share, an increase from $1.41 in the previous year, indicating a sustained improvement in the company's profitability.
  • Market Reaction: This earnings growth reflects the company's robust performance in a competitive market, potentially boosting investor confidence in its future performance and positively impacting its stock price.
  • Financial Health: With the increase in earnings, Innospec's financial condition improves further, likely providing more funding support for future investments and expansions, thereby strengthening its market position.
  • Strategic Outlook: The growth in adjusted earnings indicates the company's success in cost control and operational efficiency, suggesting continued business growth and shareholder returns in the future.
Globenewswire
9.5
01-12Globenewswire
Innospec Inc. Schedules Q4 2025 Earnings Release and Conference Call
  • Earnings Release Schedule: Innospec will release its Q4 2025 earnings on February 17, 2026, after market close, providing investors with updated financial performance data to assess the company's operational status.
  • Interactive Conference Call: The company will host a conference call on February 18, 2026, at 9:00 a.m. ET, led by CEO Patrick S. Williams and CFO Ian Cleminson, aimed at engaging investors and enhancing transparency.
  • Registration Process: The public can participate in the call by registering in advance, receiving a confirmation email with dial-in numbers, ensuring smooth access for participants and fostering a sense of involvement.
  • Webcast and Replay: The call will be simultaneously broadcasted on the company's website, with a replay available for 30 days post-call, ensuring that investors who cannot attend live can still access critical information, thereby broadening the reach of the communication.
NASDAQ.COM
4.0
2025-12-04NASDAQ.COM
Fresh Strong Sell Stocks for December 4th
  • Stocks Added to Zacks Rank #5: Boise Cascade Company, Eastman Chemical Company, and Innospec Inc. have been added to the Zacks Rank #5 (Strong Sell) List due to significant downward revisions in their earnings estimates over the past 60 days.

  • Earnings Estimate Revisions: Boise Cascade's earnings estimate was revised down by 17.9%, Eastman Chemical's by 6.6%, and Innospec's by 5.6% for the current year.

  • Top Stock Recommendations: Zacks Investment Research has revealed their Top 5 stock recommendations, highlighting one that could significantly outperform previous successful picks.

  • Access to Stock Analysis Reports: Free stock analysis reports for Eastman Chemical, Boise Cascade, and Innospec are available for those interested in further insights.

Benzinga
6.0
2025-11-18Benzinga
Lumentum Analyst Starts Coverage Optimistically; Check Out Tuesday's Top 5 Initiations
  • Analyst Coverage Initiations: Several Wall Street analysts have initiated coverage on various companies, providing new ratings and price targets for investors to consider.

  • Kestra Medical Technologies: BTIG analyst Marie Thibault rated Kestra Medical Technologies Ltd (KMTS) as a Buy with a price target of $32, while the stock closed at $25.10.

  • Innospec Inc: Freedom Capital Markets analyst David Silver also rated Innospec Inc (IOSP) as a Buy, setting a price target of $93, with shares closing at $72.23.

  • Other Notable Ratings: UBS's Michael Goldsmith rated Sabra Health Care REIT Inc (SBRA) as Neutral with a $20 target, while Mizuho's Vijay Rakesh rated Lumentum Holdings Inc (LITE) as Outperform with a $290 target.

Wall Street analysts forecast IOSP stock price to rise
1 Analyst Rating
Wall Street analysts forecast IOSP stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
93.00
Averages
93.00
High
93.00
Current: 0.000
sliders
Low
93.00
Averages
93.00
High
93.00
Freedom Capital
initiated
$93
AI Analysis
2025-11-17
Reason
Freedom Capital
Price Target
$93
AI Analysis
2025-11-17
initiated
Reason
Freedom Capital initiated coverage of Innospec with a Buy rating and $93 price target, calling the company an "undervalued" specialty chemicals maker. The firm said it sees potential upside from either new product offerings or opportunistic M&A. Freedom Capital noted that the stock's recent underperformance along with its bottoming earnings "create an attractive risk-reward tradeoff."
Seaport Global
Michael Harrison
Hold
to
Strong Buy
Upgrades
$155
2025-04-21
Reason
Seaport Global
Michael Harrison
Price Target
$155
2025-04-21
Upgrades
Hold
to
Strong Buy
Reason

Valuation Metrics

The current forward P/E ratio for Innospec Inc (IOSP.O) is 14.46, compared to its 5-year average forward P/E of 17.57. For a more detailed relative valuation and DCF analysis to assess Innospec Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
17.57
Current PE
14.46
Overvalued PE
19.96
Undervalued PE
15.17

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
10.74
Current EV/EBITDA
8.15
Overvalued EV/EBITDA
12.29
Undervalued EV/EBITDA
9.20

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.37
Current PS
1.02
Overvalued PS
1.57
Undervalued PS
1.17

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

pE <10
Intellectia · 2866 candidates
Pe Ttm: <= 10
Ticker
Name
Market Cap$
top bottom
SLG logo
SLG
SL Green Realty Corp
3.35B
AVDL logo
AVDL
Avadel Pharmaceuticals PLC
2.11B
HUBS logo
HUBS
HubSpot Inc
15.84B
ARWR logo
ARWR
Arrowhead Pharmaceuticals Inc
9.42B
PDFS logo
PDFS
PDF Solutions Inc
1.42B
TRVG logo
TRVG
Trivago NV
197.86M
best copper stock to buy
Intellectia · 44 candidates
Market Cap: >= 1000.00MSector: Basic MaterialsEps Ttm: >= 0Weekly Average Turnover: >= 1,000,000Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
IOSP logo
IOSP
Innospec Inc
2.01B
MTX logo
MTX
Minerals Technologies Inc
2.10B
AMBP logo
AMBP
Ardagh Metal Packaging SA
2.56B
APD logo
APD
Air Products and Chemicals Inc
58.57B
AUGO logo
AUGO
Aura Minerals Inc
5.47B
ECVT logo
ECVT
Ecovyst Inc
1.25B

Whales Holding IOSP

T
Tontine Management, LLC
Holding
IOSP
-1.76%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Innospec Inc (IOSP) stock price today?

The current price of IOSP is 70.64 USD — it has increased 0.06

What is Innospec Inc (IOSP)'s business?

Innospec Inc. develops, manufactures, blends, markets, and supplies a wide range of specialty chemicals to customers in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. The Company operates through three segments: Performance Chemicals, Fuel Specialties and Oilfield Services. The Company’s Performance Chemicals business creates technology-based solutions for the personal care, home care, agrochemical, construction, mining, and other industrial markets. This segment serves multinational companies, manufacturers of personal care and home care products and global mining, agricultural and building products and other industrial companies. The Company’s Fuel Specialties segment develops, manufactures, blends, markets, and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Company’s Oilfield Services business supplies drilling, completion, and production chemicals.

What is the price predicton of IOSP Stock?

Wall Street analysts forecast IOSP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IOSP is93.00 USD with a low forecast of 93.00 USD and a high forecast of 93.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Innospec Inc (IOSP)'s revenue for the last quarter?

Innospec Inc revenue for the last quarter amounts to 455.60M USD, decreased -2.40

What is Innospec Inc (IOSP)'s earnings per share (EPS) for the last quarter?

Innospec Inc. EPS for the last quarter amounts to 1.91 USD, decreased -167.73

How many employees does Innospec Inc (IOSP). have?

Innospec Inc (IOSP) has 2450 emplpoyees as of March 11 2026.

What is Innospec Inc (IOSP) market cap?

Today IOSP has the market capitalization of 1.75B USD.